Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Prenatal Testing
- History of Prenatal Testing
- Most Common Chromosomal Abnormalities
- Down Syndrome
- Trisomy 13 and Trisomy 18
- Sex Chromosome Differences
- Neural Tube Defects
- Noninvasive Techniques
- Noninvasive Prenatal Test/Cell-Free DNA Screening
- Maternal Serum Screening Test
- Ultrasound Testing
- Others
- Invasive Techniques
- Chorionic Villus Sampling
- Amniocentesis
Chapter 3 Market Dynamics
- Factors Affecting the Prenatal Testing Market
- Market Drivers
- Increase in Down Syndrome
- Increase in Rare Genetic Disorders
- Increasing Maternal Age
- Advancements in Technology
- Restraints
- High Cost of Testing
- False Positives and Negatives Results
- Future Opportunities
- Expanding Applications
- Emerging Markets
- Personalized Medicine
- Challenges
- Regulatory Hurdles
- Public Perception
- Noninvasive Prenatal Testing Coverage Challenges: Policy Disparities
Chapter 4 Emerging and Upcoming Technologies in the Market
- Introduction
- Enhancing Copy Number Variation Detection Through Whole-Genome Sequencing
- Single Nucleotide Polymorphisms Analysis
- Whole-Exome Sequencing
- Advanced Imaging Techniques
- Liquid Biopsy for Cancer Detection
- Artificial Intelligence in Prenatal Testing
Chapter 5 Market Segmentation Analysis
- Segmentation by Product Type
- Market Size
- Consumables
- Instruments
- Segmentation by Technology
- Overview
- Market Share
- Noninvasive Techniques
- Invasive Techniques
- Segmentation by Application
- Overview
- Market Share
- Neural Tube Defects
- Down Syndrome
- Rare Genetic Disorders
- Others
- Segmentation by End User
- Overview
- Market Share
- Diagnostic Laboratories
- Hospitals
- Geographic Breakdown
- Overview
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Landscape
- Mergers, Acquisitions and Collaborations
- Prenatal Testing Manufacturers and Service Providers Market Shares
- Patent Review and New Developments
- Overview
- Patent Analysis by Year
Chapter 7 ESG Development
- Introduction
- Sustainability of Prenatal Testing in Industry
List of Tables
Summary Table: Global Prenatal Testing Market, by Product, Through 2028
Table 1: Timeline of Technology Development of Prenatal Testing, 1956-2017
Table 2: Chance for Down Syndrome, by Age
Table 3: Price Per Prenatal Testing Strategy, 2021
Table 4: Global Prenatal Testing Market, by Product, Through 2028
Table 5: Global Consumables Products Market in Prenatal Testing, by Region, Through 2028
Table 6: Global Instruments Products Market in Prenatal Testing, by Region, Through 2028
Table 7: Global Prenatal Testing Market, by Technology, Through 2028
Table 8: Global Noninvasive Techniques Market in Prenatal Testing, by Type, Through 2028
Table 9: Global Noninvasive Prenatal Testing Market, by Region, Through 2028
Table 10: Global Maternal Serum Screening Market, by Region, Through 2028
Table 11: Global Ultrasound-Based Testing Market, by Region, Through 2028
Table 12: Global Others Noninvasive Techniques Market, by Region, Through 2028
Table 13: Global Invasive Techniques in Prenatal Testing Market, by Type, Through 2028
Table 14: Global Amniocentesis Invasive Techniques Market, by Region, Through 2028
Table 15: Global Chorionic Villus Sampling Invasive Techniques Market, by Region, Through 2028
Table 16: Global Others Invasive Techniques Market, by Region, Through 2028
Table 17: Global Prenatal Testing Market, by Application, Through 2028
Table 18: Global Neural Tube Defects Market in Prenatal Testing, by Region, Through 2028
Table 19: Global Down Syndrome Market in Prenatal Testing, by Region, Through 2028
Table 20: Global Rare Genetic Disorders Market in Prenatal Testing, by Region, Through 2028
Table 21: Global Other Application Market in Prenatal Testing, by Region, Through 2028
Table 22: Global Prenatal Testing Market, by End User, Through 2028
Table 23: Global Prenatal Testing Market in Diagnostic Laboratories, by Region, Through 2028
Table 24: Global Prenatal Testing Market in Hospitals, by Region, Through 2028
Table 25: Global Prenatal Testing Market, by Region, Through 2028
Table 26: North American Prenatal Testing Market, by Country, Through 2028
Table 27: European Prenatal Testing Market, by Country, Through 2028
Table 28: Asia-Pacific Prenatal Testing Market, by Country, Through 2028
Table 29: Mergers and Acquisitions: Prenatal Testing Manufacturers and Service Providers
Table 30: Patent Analysis, by Year, 2020-August 2023
Table 31: Major Patents in Prenatal Testing, by Applicant, 2023-February 2024
Table 32: ESG Highlights, by Major Players, 2022
Table 33: ESG Rankings of Major Companies Manufacturing Prenatal Testing, 2023
Table 34: Abbreviations
Table 35: Report Sources
Table 36: 10X Genomics: Company Snapshot
Table 37: 10X Genomics: Financial Performance, FY 2022 and 2023
Table 38: 10X Genomics: Product Portfolio
Table 39: 10X Genomics: News and Key Developments, 2023
Table 40: Agilent Technologies Inc.: Company Snapshot
Table 41: Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 42: Agilent Technologies Inc.: Product Portfolio
Table 43: Agilent Technologies Inc.: News and Key Developments, 2020-2023
Table 44: BGI: Company Snapshot
Table 45: BGI Genomics: Product Portfolio
Table 46: BGI Genomics: News and Key Developments, 2023 and 2024
Table 47: Eurofins Scientific: Company Snapshot
Table 48: Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 49: Eurofins Scientific: Product Portfolio
Table 50: Eurofins Scientific: News and Key Developments, 2022
Table 51: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 52: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 53: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 54: F. Hoffmann-La Roche Ltd.: News and Key Developments, 2022 and 2023
Table 55: Illumina Inc.: Company Snapshot
Table 56: Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 57: Illumina Inc.: Product Portfolio
Table 58: Illumina Inc.: News and Key Developments, 2022-2024
Table 59: Laboratory Corporation of America Holdings: Company Snapshot
Table 60: Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 61: Laboratory Corporation of America Holdings: Product Portfolio
Table 62: Laboratory Corporation of America Holdings: News and Key Developments, 2022-2024
Table 63: Medicover Genetics: Company Snapshot
Table 64: Medicover Genetics: Product Portfolio
Table 65: Medicover Genetics: News and Key Developments, 2022 and 2023
Table 66: Natera Inc.: Company Snapshot
Table 67: Natera Inc.: Financial Performance, FY 2021 and 2022
Table 68: Natera Inc.: Product Portfolio
Table 69: Natera Inc.: News and Key Developments, 2024
Table 70: Qiagen: Company Snapshot
Table 71: QIAGEN: Annual Financials/Revenue, 2021 and 2022
Table 72: Qiagen: Product Portfolio
Table 73: Qiagen: News and Key Developments, 2022-2024
Table 74: Quest Diagnostic Inc.: Company Snapshot
Table 75: Quest Diagnostic Inc.: Financial Performance, FY 2022 and 2023
Table 76: Quest Diagnostic Inc.: Product Portfolio
Table 77: Quest Diagnostic Inc.: News and Key Developments, 2021-2024
Table 78: Revvity Inc.: Company Snapshot
Table 79: Revvity Inc.: Financial Performance, FY 2021 and 2022
Table 80: Revvity Inc.: Product Portfolio
Table 81: Revvity Inc.: News and Key Developments, 2021-2023
Table 82: Thermo Fisher Scientific Inc.: Company Snapshot
Table 83: Thermo Fisher Scientific Inc.: Annual Financials/Revenue, 2021 and 2022
Table 84: Thermo Fisher Scientific Inc.: Product Portfolio
Table 85: Thermo Fisher Scientific Inc.: News and Key Developments, 2022 and 2023
Table 86: Yourgene Health: Company Snapshot
Table 87: Yourgene Health Product Portfolio
Table 88: Yourgene Health News/Key Developments, 2022 and 2023
List of Figures
Summary Figure: Global Prenatal Testing Market, by Product, 2020-2028
Figure 1: Down Syndrome Karyotype
Figure 2: Market Dynamics: Global Prenatal Testing Market
Figure 3: Universal NIPT Coverage Across Payer Networks, 2020
Figure 4: Global Prenatal Testing Market, by Segment Analysis
Figure 5: Global Prenatal Testing Market, by Product, 2020-2028
Figure 6: Global Consumables Products Market in Prenatal Testing, by Region, 2020-2028
Figure 7: Global Instruments Products Market in Prenatal Testing, by Region, 2020-2028
Figure 8: Global Prenatal Testing Market, by Technology, 2020-2028
Figure 9: Global Noninvasive Techniques Market in Prenatal Testing, by Type, 2020-2028
Figure 10: Global Noninvasive Prenatal Testing Market, by Region, 2020-2028
Figure 11: Global Maternal Serum Screening Market, by Region, 2020-2028
Figure 12: Global Ultrasound-Based Testing Market, by Region, 2020-2028
Figure 13: Global Others Noninvasive Techniques Market, by Region, 2020-2028
Figure 14: Global Invasive Techniques in Prenatal Testing Market, by Type, 2020-2028
Figure 15: Global Amniocentesis Invasive Techniques Market, by Region, 2020-2028
Figure 16: Global Chorionic Villus Sampling Invasive Techniques Market, by Region, 2020-2028
Figure 17: Global Others Invasive Techniques Market, by Region, 2020-2028
Figure 18: Global Prenatal Testing Market, by Application, 2020-2028
Figure 19: Global Neural Tube Defects Market in Prenatal Testing, by Region, 2020-2028
Figure 20: Global Down Syndrome Market in Prenatal Testing, by Region, 2020-2028
Figure 21: Global Rare Genetic Disorders Market in Prenatal Testing, by Region, 2020-2028
Figure 22: Global Other Application Market in Prenatal Testing, by Region, 2020-2028
Figure 23: Global Prenatal Testing Market, by End User, 2020-2028
Figure 24: Global Prenatal Testing Market in Diagnostic Laboratories, by Region, 2020-2028
Figure 25: Global Prenatal Testing Market, in Hospitals, by Region, 2020-2028
Figure 26: Global Prenatal Testing Market, by Region, 2020-2028
Figure 27: Global Prenatal Testing Market Share, by Region, 2022
Figure 28: North American Prenatal Testing Market, by Country, 2020-2028
Figure 29: European Prenatal Testing Market, by Country, 2020-2028
Figure 30: Asia-Pacific Prenatal Testing Market, by Country, 2020-2028
Figure 31: Global Prenatal Testing Market Shares, by Key Manufacturers and Service Providers 2022
Figure 32: Published Patent Share, by Country, 2020-2023
Figure 33: Business Benefits of a Strong ESG Proposition
Figure 34: ESG-Adoption Level Across All the Industries, 2021 and 2022
Figure 35: 10 Business Sustainability Trends Identified for 2023
Figure 36: 10X Genomics: Revenue Share, by Business Unit, FY 2023
Figure 37: 10X Genomics: Revenue Share, by Country/Region, FY 2023
Figure 38: Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 39: Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 40: Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
Figure 41: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43: Illumina Inc.: Revenue Share, by Business Unit, FY 2022
Figure 44: Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45: Laboratory Corporation of America Holdings: Revenue Share, by Business Unit, FY 2023
Figure 46: Laboratory Corporation of America Holdings: Revenue Share, by Country/Region, FY 2023
Figure 47: Natera Inc.: Revenue Share, by Business Unit, FY 2022
Figure 48: Natera Inc.: Revenue Share, by Country/Region, FY 2022
Figure 49: Qiagen: Revenue Share, by Business Unit, 2022
Figure 50: Qiagen: Revenue Share, by Region, 2022
Figure 51: Quest Diagnostic Inc.: Revenue Share, by Business Unit, FY 2023
Figure 52: Revvity Inc.: Revenue Share, by Business Unit, FY 2022
Figure 53: Revvity Inc.: Revenue Share, by Country/Region, FY 2022
Figure 54: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2022
Figure 55: Thermo Fisher Scientific Inc.: Revenue Share, by Region, 2022
